Itraconazole is a triazole antifungal used in dogs for many systemic and deep fungal infections, including blastomycosis, histoplasmosis, coccidioidomycosis, some forms of aspergillosis and selected dermatophyte infections. It is generally more potent and better tolerated than ketoconazole for many of these diseases and has become one of the main oral antifungals used in veterinary medicine.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion
Its usefulness comes with practical limitations. Itraconazole is highly lipophilic, its absorption depends on formulation, and it can cause liver injury or gastrointestinal adverse effects. Capsules and oral solutions are not always pharmacokinetically interchangeable. Compounded products can also vary. For a dog facing months of treatment, formulation and consistency matter almost as much as the drug name.
How itraconazole works
Itraconazole inhibits fungal lanosterol 14-alpha-demethylase, a cytochrome P450 enzyme needed for ergosterol synthesis. Ergosterol is essential to fungal cell membranes, so blocking its production disrupts membrane function and fungal growth.
It belongs to the triazole group with fluconazole and newer agents such as voriconazole and posaconazole. Compared with ketoconazole, itraconazole usually has a more favorable antifungal spectrum and less interference with mammalian steroid synthesis.
Which fungal diseases may be treated?
Itraconazole is widely used against dimorphic fungi and dermatophytes. Merck Veterinary Manual lists activity against organisms associated with blastomycosis, histoplasmosis, coccidioidomycosis, sporotrichosis and some aspergillosis.
The drug chosen depends on where infection is located, how sick the dog is, organism susceptibility, cost and the ability to maintain treatment long enough.
Blastomycosis
Blastomycosis can affect lungs, skin, bones, eyes and other organs. Itraconazole is commonly used for canine disease because it reaches many tissues and has strong activity against Blastomyces.
Respiratory signs can occasionally worsen early in treatment as fungal organisms die and inflammation increases. A dog with severe pulmonary disease may need hospitalization, oxygen or adjunctive treatment rather than simply continuing tablets at home without reassessment.
Histoplasmosis
Histoplasma infection can involve the gastrointestinal tract, liver, spleen, lymph nodes, lungs, eyes and bone marrow. Weight loss, diarrhea and poor appetite may be prominent.
Itraconazole is often used for systemic disease, but dogs that are very ill may need intensive supportive care. Long therapy and monitoring for relapse are common.
Coccidioidomycosis
Dogs exposed in endemic desert regions may develop respiratory, bone, joint or disseminated coccidioidomycosis. Itraconazole can be used when disease is extensive or when another azole is not adequate.
Because coccidioidomycosis may require many months of treatment, cost and tolerability become important practical considerations.
Aspergillosis
Itraconazole has substantially better activity against Aspergillus than fluconazole, but response depends on whether disease is nasal, disseminated or involves a resistant strain. Local therapy may be preferred for sinonasal aspergillosis, while disseminated infection can require systemic azoles or combination treatment.
Merck notes that itraconazole and voriconazole resistance can occur in Aspergillus isolates. Lack of improvement should prompt reassessment rather than indefinite continuation.
Dermatophytes and ringworm
Itraconazole can be used for dermatophytosis, particularly when lesions are widespread, multiple animals are affected or topical therapy alone is impractical. Environmental control remains essential because infected hairs contaminate the home.
Dogs with ringworm can transmit infection to people, especially children or immunocompromised household members. Treatment should include a plan for the environment and exposed animals.
Capsules and oral solution behave differently
Itraconazole formulations are not always interchangeable. Human capsules, oral solution and compounded veterinary products can have different absorption. Food can affect them differently as well.
Follow the instructions for the exact formulation dispensed. If the pharmacy changes from capsules to liquid, confirm the new directions rather than carrying over the previous milliliter or meal routine.
Why food matters
Conventional itraconazole capsules are generally absorbed better with food and gastric acidity. Oral solution may have different recommendations. Acid-suppressing drugs can reduce absorption of some formulations.
If the dog takes omeprazole, famotidine or another antacid, make sure the veterinarian knows before choosing the itraconazole product and schedule.
Compounded itraconazole
Compounding is sometimes necessary for very small dogs or unusual dosage needs, but compounded itraconazole products have historically shown variable bioavailability depending on formulation and pharmacy quality.
If a dog fails to improve on a compounded product, inadequate exposure belongs on the list of possibilities. Do not assume the organism is resistant before reviewing formulation and adherence.
Itraconazole dosage by weight: disease and formulation matter
Merck’s general canine azole reference lists itraconazole at 5–10 mg/kg by mouth every 12–24 hours. Its integumentary fungal-disease guidance gives 5 mg/kg once daily for dermatophytosis and 5–10 mg/kg once daily for systemic mycoses. These ranges explain why the diagnosis and formulation matter more than a single generic chart.
| Reference context | Published canine guidance |
|---|---|
| General azole reference | 5–10 mg/kg PO every 12–24 hours |
| Dermatophytosis | 5 mg/kg PO every 24 hours until mycological cure |
| Systemic mycoses | 5–10 mg/kg PO every 24 hours, often for prolonged treatment |
Sources: Merck azole pharmacology and Merck antifungal disease guidance. Capsules, oral solutions and compounded products are not always interchangeable in absorption.
Gastrointestinal side effects
Vomiting, diarrhea and reduced appetite can occur. These are especially important in dogs already losing weight from systemic fungal disease.
If appetite declines substantially, call the clinic. A dog should not become malnourished while everyone waits for the infection to improve.
Liver toxicity
Itraconazole can increase liver enzymes and, less commonly, cause clinically significant hepatotoxicity. Baseline chemistry and periodic follow-up are often sensible for long treatment courses.
Jaundice, persistent vomiting, dark urine, marked lethargy or severe appetite loss require prompt veterinary review.
Cutaneous vasculitis-like reactions
Dogs can rarely develop unusual skin reactions during itraconazole therapy, including ulcerative or vasculitic lesions. New painful skin sores, swelling or tissue injury should not automatically be attributed to the fungal disease.
Photograph new lesions and contact the veterinarian so the drug and diagnosis can be reviewed.
Why dose and exposure matter
Too little exposure can allow a deep fungal infection to persist; too much can increase adverse effects. Body weight, formulation, food, gastric acidity, liver function and concurrent medicines all influence exposure.
That is why a dosing calculator cannot safely replace a prescription for systemic antifungal therapy.
Drug interactions
Itraconazole inhibits hepatic CYP enzymes and can increase concentrations of other medicines. It can interact with immunosuppressants, some cardiovascular drugs, sedatives and other medications.
Bring a complete medication and supplement list to every recheck. New prescriptions from another clinic should be screened before the first dose.
Itraconazole and cyclosporine
Itraconazole can raise cyclosporine concentrations. Veterinarians may sometimes take advantage of that interaction, but doing so requires deliberate dose planning and monitoring.
Do not combine them simply to lower the cost of cyclosporine without veterinary supervision.
Itraconazole and acid suppressants
Proton-pump inhibitors and H2 blockers can reduce absorption of conventional itraconazole capsules by raising gastric pH. This interaction is easy to overlook because the antacid may have been prescribed for an unrelated problem months earlier.
The veterinarian may change timing, formulation or antifungal choice rather than stopping needed gastrointestinal treatment abruptly.
Itraconazole and seizure medicines
Phenobarbital and other enzyme-inducing anticonvulsants can alter azole exposure, and itraconazole can affect metabolism of other drugs. Dogs with epilepsy and systemic fungal disease need medication review across both conditions.
Do not stop seizure treatment to make the antifungal work better. The two plans should be coordinated.
What if a dose is missed?
Do not double the next dose automatically. Long antifungal courses depend on consistent administration, but stacking doses can increase toxicity.
If several doses are missed, call the clinic because the treatment timeline or monitoring plan may need adjustment.
What if an extra dose is given?
An extra dose may increase gastrointestinal or hepatic adverse effects. Contact a veterinarian with the exact formulation, strength, amount involved, dog’s weight and other medications.
A large ingestion should be discussed promptly even if the dog initially appears well.
Itraconazole versus fluconazole
Itraconazole generally has stronger activity against molds such as Aspergillus, while fluconazole offers excellent penetration into cerebrospinal fluid and urine. The site and organism determine which advantage matters more.
Switching between them should be diagnosis-driven, not based only on which tablet is cheaper.
Itraconazole versus ketoconazole
Itraconazole is often better tolerated and has broader useful antifungal activity. Ketoconazole may still be chosen in some cases because of cost or clinician experience.
Ketoconazole has stronger effects on mammalian steroid synthesis and more dependence on gastric acidity, while itraconazole’s main practical issues are formulation, absorption and hepatic effects.
Itraconazole versus terbinafine
Terbinafine blocks a different step of ergosterol synthesis and is particularly useful for dermatophytes. Some difficult infections are treated with combinations, but evidence varies and adverse effects still need monitoring.
Combination therapy should have a specific rationale, not simply reflect the idea that two antifungals must be stronger than one.
Why treatment often continues after symptoms improve
Clinical signs can resolve before infection is controlled enough to prevent relapse. Systemic mycoses may require weeks or months beyond obvious improvement.
The endpoint can involve imaging, antigen testing, lesion resolution, repeated cultures or a defined symptom-free period depending on the disease.
Antigen monitoring
For some fungal diseases, antigen assays help track burden over time. A falling result can support improvement, while persistent elevation can prompt review.
The test is one piece of evidence. Treatment should not be changed solely from a number without considering the dog.
Eye involvement
Blastomycosis, cryptococcosis and other fungal diseases can affect the eye. Redness, squinting, cloudiness or sudden visual changes deserve prompt ophthalmic examination.
Systemic itraconazole may be part of therapy, but local treatment or another drug may be required to protect vision.
Neurologic involvement
Itraconazole penetrates the CNS less predictably than fluconazole. When fungal infection involves brain or spinal tissue, the veterinarian may choose another azole or a combination based on organism and severity.
New seizures, circling, neck pain or weakness require urgent reassessment.
Pregnancy and breeding animals
Azoles can affect fetal development and steroid metabolism. Breeding, pregnant and nursing dogs require individualized risk assessment.
Do not give leftover itraconazole to a pregnant dog without professional guidance.
How to make a long course safer
Use a written medication schedule, order refills before the bottle is empty and record vomiting, appetite changes and missed doses. Long treatments fail through practical problems as often as through pharmacology.
If administration becomes difficult, ask about another formulation rather than letting adherence drift.
Monitoring plan
Follow-up can include weight, appetite, liver values, complete blood count, fungal antigen testing and disease-specific imaging. The schedule depends on infection and treatment duration.
Bring the current bottle to rechecks if formulation or pharmacy has changed.
Questions to ask
Ask what fungus is suspected, why itraconazole was chosen, which formulation is being dispensed, whether food or stomach-acid medication affects absorption and how long treatment is expected to continue.
Ask which signs suggest liver toxicity and what objective endpoint will be used before stopping therapy.
Reliable references
The Merck Veterinary Manual azole review describes itraconazole’s antifungal spectrum, pharmacology and veterinary use. Disease-specific fungal references should guide duration and combination therapy.
Why pharmacy consistency matters
Itraconazole is unusually sensitive to formulation differences. If a dog is stable on one product and the pharmacy changes manufacturer, dosage form or compounded preparation, note the date and watch clinical response carefully. A later change in symptoms may reflect altered absorption rather than sudden fungal resistance.
For a long course, consistency is often safer than frequent switching based only on price.
Bottom line
Itraconazole is one of the most useful oral antifungals in dogs because it has broad activity against important systemic fungi and better tolerability than older ketoconazole in many patients. Its main practical risks are liver effects, gastrointestinal intolerance, drug interactions and inconsistent absorption between formulations.
Use the exact prescribed product, follow food instructions for that formulation, monitor long courses and do not stop treatment just because symptoms improve early.
DogMedsHub provides source-backed canine medication guidance and does not diagnose, prescribe or replace veterinary care.
Why a formulation change can look like disease progression
A dog may be stable for months and then appear to relapse shortly after a pharmacy or formulation change. Before assuming the fungus has become resistant, check whether the new product is a capsule, oral solution or compounded preparation with different absorption. Itraconazole exposure is sensitive to formulation, and a change in bioavailability can matter clinically.
Keep a note of the manufacturer, formulation and date of each change. That information can be surprisingly useful when the veterinary team is trying to explain a sudden shift in response.
Why weight loss deserves attention
Systemic fungal disease commonly causes weight loss, but so can persistent nausea and reduced food intake from medication. Weigh the dog regularly during a long course, ideally on the same scale. A continuing downward trend should prompt review of appetite, disease control and drug tolerance.
Do not rely on body condition alone in a long-haired dog. Measured weight and muscle condition can reveal decline earlier.
When another infection appears during treatment
A dog being treated for a fungal disease can still develop bacterial skin, ear or urinary infections. New fever, discharge, pustules or urinary signs should be evaluated on their own merits. Adding an antibiotic without diagnostics can create additional adverse effects and make the original picture harder to interpret.
Likewise, a new cough during treatment is not automatically fungal relapse. Heart disease, bacterial pneumonia or airway disease may coexist.
What remission means in a chronic fungal disease
For some mycoses, veterinarians speak more realistically about remission or long-term control than absolute eradication. A dog may need extended therapy, periodic antigen testing or renewed treatment if signs recur.
Understanding that possibility early helps owners plan financially and emotionally for a disease that may not behave like a simple two-week infection.
Why a specialist referral can be worthwhile
Internal-medicine or dermatology referral can be useful when diagnosis is uncertain, the disease has reached the eyes or nervous system, treatment is failing, or the dog cannot tolerate first-line therapy. Specialists may have access to advanced imaging, fungal testing and newer antifungal options.
Referral does not mean the primary veterinarian has failed; it can shorten the path to a better-defined diagnosis when the case becomes complex.
Household exposure and public-health context
Most systemic environmental mycoses are acquired from the environment rather than directly from an infected dog, while dermatophytes can spread between animals and people. Ask the veterinarian whether the particular fungus poses a household-transmission concern.
That distinction prevents unnecessary isolation for diseases that are not normally contagious and ensures proper cleaning when a contagious dermatophyte is involved.
Do not use treatment response as the only diagnostic test
Improvement on itraconazole can support a fungal diagnosis, but it is not definitive proof. Some inflammatory diseases fluctuate, and itraconazole has effects beyond simple fungal killing. When feasible, obtaining a specific diagnosis before months of therapy is better practice.
If diagnostic samples are likely to be needed, ask whether they should be collected before treatment changes the organism burden.
